Found: 1
Select item for more details and to access through your institution.
Altered intracellular signaling by imatinib increases the anti‐cancer effects of tyrosine kinase inhibitors in chronic myelogenous leukemia cells.
- Published in:
- Cancer Science, 2018, v. 109, n. 1, p. 121, doi. 10.1111/cas.13442
- By:
- Publication type:
- Article